Related Experiment Video
Updated: Aug 6, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Idiopathic inflammatory demyelinating disorders after acute transverse myelitis
K H Chan1, K L Tsang, G C Y Fong
1Division of Neurology, University Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Abstract:
Acute transverse myelitis (ATM) is commonly para-infectious. Recurrent ATM occurs in connective tissue diseases (CTD), infective myelitis and idiopathic inflammatory demyelinating disorders (IIDD) including multiple sclerosis (MS) and neuromyelitis optica (NMO). Previous studies might include NMO and idiopathic recurrent transverse myelitis (IRTM) as MS. The aim was to study the outcome of patients after a first attack of idiopathic ATM. Idiopathic ATM patients over a 6-year period were retrospectively studied. Known causes of myelopathy were excluded. Among 32 patients studied, 20 (63%) had single ATM attack upon follow up for 39-93 months, three developed recurrent ATM related to CTD (two systemic lupus erythematosus and one anti-Ro antibody positive) and nine (28.1%) developed recurrent neuroinflammation compatible with IIDD. Among IIDD patients, three had NMO, two restricted variant of NMO, three IRTM and one classical MS. NMO, its variant and IRTM had mean spinal MRI abnormality of 3.7, 2.1 and 3.9 vertebral segments respectively while non-recurrent ATM had 1.6 vertebral segments. Four (80%) of the five patients with NMO or its variant had poor neurological prognosis versus only one (5%) of non-recurrent ATM patients. IRTM patients had advanced mean onset age, 62 years vs. 43 years for non-recurrent ATM patients. In IIDD patients presenting with ATM as first attack of neuroinflammation, NMO and its variant (56%) were most frequent, then IRTM (33%), with classical MS (11%) the rarest. As long-term treatments for NMO are different from MS, early recognition of NMO and its variant is important for prevention of serious neurological deficits.
Insights
Recurrent acute transverse myelitis (ATM) can indicate connective tissue diseases or idiopathic inflammatory demyelinating disorders like neuromyelitis optica (NMO). Early NMO recognition is vital for distinct treatment and preventing deficits.
Area of Science:
- Neurology
- Immunology
- Demyelinating Diseases
Background:
- Acute transverse myelitis (ATM) is often post-infectious.
- Recurrent ATM is associated with connective tissue diseases (CTD) and idiopathic inflammatory demyelinating disorders (IIDD), including multiple sclerosis (MS) and neuromyelitis optica (NMO).
- Previous research may have misclassified NMO and idiopathic recurrent transverse myelitis (IRTM) as MS.
Purpose of the Study:
- To investigate the long-term outcomes of patients experiencing their first idiopathic ATM attack.
- To differentiate between single ATM, recurrent ATM linked to CTD, and recurrent neuroinflammation indicative of IIDD.
- To assess the diagnostic and prognostic significance of MRI findings and clinical presentation in IIDD.
Main Methods:
- Retrospective study of idiopathic ATM patients over six years.
- Exclusion of known causes of myelopathy.
- Follow-up assessments including neurological examination and spinal MRI.
Main Results:
- Of 32 patients, 63% had a single ATM attack.
- 9 patients (28.1%) developed recurrent neuroinflammation consistent with IIDD (3 NMO, 2 NMO variants, 3 IRTM, 1 MS).
- NMO and its variants showed significantly greater spinal MRI abnormalities and poorer neurological prognosis compared to non-recurrent ATM.
Conclusions:
- Idiopathic ATM can be the initial presentation of serious IIDD, particularly NMO and its variants.
- Distinguishing NMO from MS is crucial due to differing treatment strategies.
- Early identification of NMO and its variants is essential for timely intervention and improved patient outcomes.
Related Concept Videos
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Encephalitis l: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis ll: Pathophysiology
